Bisphosphonates bind to bone minerals and are taken up by osteoclasts during bone resorption. Once inside the osteoclasts, these drugs inhibit the enzymes necessary for bone breakdown, leading to osteoclast apoptosis (programmed cell death). This process helps to maintain bone density and integrity, which is particularly crucial for cancer patients with metastatic bone disease.
